New Flower-Shaped speculum aims to make pap smears easier and more comfortable
NCT ID NCT06496295
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new, FDA-cleared speculum shaped like a five-petal flower for cervical cancer screening. Researchers want to see if it gives doctors a better view of the cervix, is easier to use, and feels more comfortable for patients compared to the standard speculum. About 200 women and gender-diverse patients with an intact cervix, aged 18-65, will take part at community clinics in Denver.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bouquet Speculum (a 5-petaled vaginal speculum device)
- What this could lead to
- If it works, this could make cervical cancer screening more comfortable and effective, potentially increasing screening rates.
- What could go wrong
- This is a small, early-stage study with only 200 participants, so results may not apply to everyone. The new speculum may not be better than the standard one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Sunrise Community Health Clinics provide affordable health care to the uninsured and underinsured. This particular study involves women or gender diverse patients with a cervix and who have had a previous vaginal speculum exam.
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * women, gender diverse patients with an intact cervix * women ages 18-25 Exclusion Criteria: no prior vaginal speculum exam * under age 18 or over age 65 * lack of a uterine cervix * no prior vaginal speculum exam
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical cancer screening are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rocky Vista University
Englewood, Colorado, 80112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cervical smear DNA may reveal ovarian cancer years before symptoms
- Can a virtual promotora get more hispanic women screened for cervical cancer?
- A digital coach may guide patients through cervical cancer prevention
- Self-swabs could boost cervical cancer screening in kazakhstan
- Self-sampling for cervical cancer screening could make testing easier and more accessible
- Self-Sampling could boost cervical cancer screening for women with HIV